Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 5 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.
J Cell Mol Med. 2023 Oct;27(20):3053-3064. doi: 10.1111/jcmm.17868. Epub 2023 Aug 31.
J Cell Mol Med. 2023.
PMID: 37654003
Free PMC article.
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients.
Fontana D, Crespiatico I, Crippa V, Malighetti F, Villa M, Angaroni F, De Sano L, Aroldi A, Antoniotti M, Caravagna G, Piazza R, Graudenzi A, Mologni L, Ramazzotti D.
Fontana D, et al. Among authors: malighetti f.
Nat Commun. 2023 Sep 25;14(1):5982. doi: 10.1038/s41467-023-41670-3.
Nat Commun. 2023.
PMID: 37749078
Free PMC article.
Item in Clipboard
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells.
Cordani N, Mologni L, Piazza R, Tettamanti P, Cogliati V, Mauri M, Villa M, Malighetti F, Di Bella C, Jaconi M, Cerrito MG, Cavaletti G, Lavitrano M, Cazzaniga ME.
Cordani N, et al. Among authors: malighetti f.
Int J Mol Sci. 2023 Nov 14;24(22):16294. doi: 10.3390/ijms242216294.
Int J Mol Sci. 2023.
PMID: 38003483
Free PMC article.
Item in Clipboard
Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering.
Crippa V, Malighetti F, Villa M, Graudenzi A, Piazza R, Mologni L, Ramazzotti D.
Crippa V, et al. Among authors: malighetti f.
Comput Biol Med. 2023 Aug;162:107064. doi: 10.1016/j.compbiomed.2023.107064. Epub 2023 May 28.
Comput Biol Med. 2023.
PMID: 37267828
Free article.
Item in Clipboard
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.
Malighetti F, Arosio G, Manfroni C, Mauri M, Villa M, Manghisi B, Inzoli E, Rindone G, Zambrotta GPM, Civettini I, Guglielmana V, Ramazzotti D, Giudici G, Bombelli S, Perego R, Piazza R, Mologni L, Gambacorti-Passerini C.
Malighetti F, et al.
Hemasphere. 2023 Feb 24;7(3):e852. doi: 10.1097/HS9.0000000000000852. eCollection 2023 Mar.
Hemasphere. 2023.
PMID: 36860269
Free PMC article.
No abstract available.
Item in Clipboard
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients.
Villa M, Malighetti F, Sala E, Sharma GG, Arosio G, Gemelli M, Manfroni C, Fontana D, Cordani N, Meneveri R, Zambon A, Piazza R, Pagni F, Cortinovis D, Mologni L.
Villa M, et al. Among authors: malighetti f.
NPJ Precis Oncol. 2024 Mar 6;8(1):29. doi: 10.1038/s41698-024-00498-w.
NPJ Precis Oncol. 2024.
PMID: 38448512
Free PMC article.
Item in Clipboard
FOS Rescues Neuronal Differentiation of Sox2-Deleted Neural Stem Cells by Genome-Wide Regulation of Common SOX2 and AP1(FOS-JUN) Target Genes.
Pagin M, Pernebrink M, Pitasi M, Malighetti F, Ngan CY, Ottolenghi S, Pavesi G, Cantù C, Nicolis SK.
Pagin M, et al. Among authors: malighetti f.
Cells. 2021 Jul 12;10(7):1757. doi: 10.3390/cells10071757.
Cells. 2021.
PMID: 34359927
Free PMC article.
Item in Clipboard
Cite
Cite